Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7825580 | 0.85 | TSHR (0.40) | TSHRATMMEN1NPC1RAB9A | |
| SCHEMBL28298 | 0.80 | — | — | |
| SCHEMBL21114388 | 0.80 | TSHR (0.57) | TSHRNAPRTCYP2D6RAB9ASMN1; SMN2 | |
| SCHEMBL10141202 | 0.80 | — | — | |
| SCHEMBL10141203 | 0.80 | — | — | |
| Water SCHEMBL5567597 | 0.78 | — | — | |
| SCHEMBL4325727 | 0.78 | — | — | |
| SCHEMBL17363100 | 0.78 | — | — | |
| Phosphine SCHEMBL30485793 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL1147719 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-10139781-A | — | — | None | — | — | JP | disclosed |
| EP-2038701-B1 | ENCAPSULATED DISPERSIONS COMPRISING ELECTROPHORETICALLY MOBILE ORGANIC COLORANTS | BASF SE (DE) | 2017-04-12 | — | — | EP | disclosed |
| US-9403987-B2 | Charged particles | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| EP-2445971-B1 | CHARGED PARTICLES | BASF SE (DE) | 2013-11-27 | — | — | EP | disclosed |
| US-20120229884-A1 | CHARGED PARTICLES | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
| EP-2445971-A2 | CHARGED PARTICLES | BASF SE (DE) | 2012-05-02 | — | — | EP | disclosed |
| US-8040592-B2 | Encapsulated dispersions comprising electrophoretically mobile organic colorants | BASF SE (DE) | 2011-10-18 | — | — | US | disclosed |
| WO-2010149505-A2 | CHARGED PARTICLES | BASF SE (DE) | 2010-12-29 | — | — | WO | disclosed |
| US-20100265564-A1 | Encapsulated dispersions comprising electrophoretically mobile organic colorants | CIBA CORPORATION | 2010-10-21 | — | — | US | disclosed |
| EP-2038701-A2 | ENCAPSULATED DISPERSIONS COMPRISING ELECTROPHORETICALLY MOBILE ORGANIC COLORANTS | Ciba Holding Inc. (CH) | 2009-03-25 | — | — | EP | disclosed |
| WO-2008003619-A2 | ENCAPSULATED DISPERSIONS COMPRISING ELECTROPHORETICALLY MOBILE ORGANIC COLORANTS | CIBA HOLDING INC. (CH) | 2008-01-10 | — | — | WO | disclosed |
| US-5874588-A | Process for the preparation of diketopyrrolopyrrolecarboxylic acids and their esters and amides | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-02-23 | — | — | US | disclosed |
| JP-H10139781-A | PRODUCTION OF DIKETOPYRROLOPYRROLE CARBOXYLIC ACID, AND ESTER AND AMIDE THEREOF | CIBA SPECIALTY CHEM HOLDING INC | 1998-05-26 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120229884-A1 | CHARGED PARTICLES | POLE3, POLD3, IPO4 | TSHR 3582/4885NAPRT 2526/4885CYP2D6 4556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.